PRESS RELEASE published on 06/18/2025 at 06:45, 1 year 4 months ago Implenia wins major contract for deep geological repository in Sweden Implenia wins major contract for deep geological repository in Sweden. Contract volume of several hundred million Swiss francs. Project includes planning, design, and construction at a depth of 500m. Completion by 2033 Construction Sweden Implenia Contract Deep Geological Repository
PRESS RELEASE published on 06/18/2025 at 06:25, 1 year 4 months ago Formycon AG: Subscription period for 2025/2029 corporate bond has started Formycon AG announces the start of the subscription period for the 2025/2029 corporate bond with a target volume of EUR 50 million, featuring a variable interest rate. Investors can submit subscription offers until June 27, 2025 Growth Strategy Formycon AG Interest Rate Corporate Bond Subscription Period
PRESS RELEASE published on 06/18/2025 at 06:14, 1 year 4 months ago EQS-Adhoc: Airbus to present new dividend policy and reaffirm cash conversion target during business update on 18 June 2025 Airbus SE to present new dividend policy and reaffirm cash conversion target during business update on June 18, 2025. Strengthening commitment to increasing shareholder returns Business Update Dividend Policy Airbus SE Shareholder Returns Cash Conversion Target
PRESS RELEASE published on 06/18/2025 at 05:58, 1 year 4 months ago Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals Lobe Sciences Ltd. advances Conjugated Psilocin™ research for chronic cluster headaches and addiction via $6M investment in Cynaptec Pharmaceuticals, with option for additional $20M Clinical Trials Investment Cynaptec Pharmaceuticals Lobe Sciences Ltd. Conjugated Psilocin™
PRESS RELEASE published on 06/17/2025 at 23:00, 1 year 4 months ago New to The Street Signs Backstage ($ BKS) to 12-Part Media Series Covering Music, Sports, and Tokenized Real-World Assets in Entertainment New to The Street announces exclusive media series with Backstage (NASDAQ:BKS) for mainstream adoption of tokenized entertainment. Campaign includes TV, billboards, and editorial support New To The Street Media Series Backstage Tokenized Entertainment Mainstream Adoption
PRESS RELEASE published on 06/17/2025 at 23:00, 1 year 4 months ago Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy Medicure Inc. announces acquisition of West Olympia Pharmacy Inc., further boosting direct-to-consumer pharmacy business and sales of ZYPITAMAG(R) and BRENZAVVY(R) Acquisition Medicure Inc. Pharmacy Business ZYPITAMAG(R) BRENZAVVY(R)
PRESS RELEASE published on 06/17/2025 at 22:50, 1 year 4 months ago EQS-Adhoc: Verve Group SE: Verve successfully completes a directed share issue of 12,858,000 new shares raising proceeds of approximately SEK 360 million Verve Group SE successfully completes a directed share issue of 12,858,000 new shares raising proceeds of approximately SEK 360 million. The subscription price is SEK 28.00 per share Market Conditions Subscription Price Verve Group SE Directed Share Issue SEK 360 Million
PRESS RELEASE published on 06/17/2025 at 22:50, 1 year 4 months ago Verve Group SE (Nordic): Verve successfully completes a directed share issue of 12,858,000 new shares raising proceeds of approximately SEK 360 million Verve Group SE completes directed share issue of 12,858,000 new shares, raising SEK 360 million. Key investors include industry experts. Proceeds to fund growth initiatives and strengthen balance sheet Investor Base Share Issue Verve Group SE Directed Share Issue SEK 360 Million
PRESS RELEASE published on 06/17/2025 at 22:10, 1 year 4 months ago Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward Judy Murrah appointed Chairperson and CEO of Applied DNA Sciences, succeeding Dr. James A. Hayward. Experienced executive aims to lead company's innovative DNA technologies CEO Appointment Applied DNA Sciences DNA Technologies Judy Murrah Dr. James A. Hayward
PRESS RELEASE published on 06/17/2025 at 20:30, 1 year 4 months ago GENFIT: June 17, 2025 Combined Shareholders Meeting Results GENFIT announces approval of all resolutions at June 17, 2025 Combined Shareholders Meeting. Exception: resolution n°28 rejected. Quorum: 27.21% Resolutions Approval Quorum Shareholders Meeting GENFIT
Published on 11/06/2026 at 22:15, 21 hours 58 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 1 day 7 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 1 day 7 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 1 day 7 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/07/2026 at 13:35, 6 hours 38 minutes ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 23 hours 58 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 1 day ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 1 day 1 hour ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 1 day 1 hour ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 17:54, 1 day 2 hours ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 1 day 2 hours ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026